Clinical trial
Modified Release Posaconazole in Patients With Cystic Fibrosis
NCT03421366 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modified Release Posaconazole in Patients With Cystic Fibrosis
- Lead sponsor
- Bayside Health
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 1, 2018
- Completion date
- February 5, 2021
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.